Not applicable · NCT07226947

BICEP

BIA Monitoring and Exercise for the Prevention of Muscle Loss With Incretin Therapy (BICEP Study)

RecruitingVerified

Registry record

Trial details

Trial
BICEP
ClinicalTrials.gov ID
NCT07226947
Indication
Obesity, Body Composition
Phase
Not applicable
Study type
Interventional
Sponsor
Massachusetts General Hospital
Enrolment
100
Status
Recruiting
Interventions
Device: Smartwatch activity and body composition monitor; Behavioral: General guidance on recommended exercise
Comparator
Not reported
Eligible ages
18 Years – 99 Years
Locations
1 site · United States
Study start
24 Nov 2025
Primary completion
1 Jun 2027
Study completion
1 Jun 2027
View registry record →

Verification

Last verified
4 Sept 2026
Source
ClinicalTrials.gov
Registry last updated
30 Dec 2025

Endpoints

Primary

Lean mass (kg)

Secondary

Lean mass index (kg/m2); Appendicular lean mass index (kg/m2); Fat mass index (kg/m2); Fat mass (kg); Visceral adipose tissue (kg); Lean mass/fat mass ratio; Fat free mass; Hand grip strength (kg); 1-minute sit-to-stand; 6-minute walk test; Short Physical Performance Battery frailty score (total points); Physical activity score